Multicenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin.

scientific article published on 13 June 2016

Multicenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/AAC.00630-16
P8608Fatcat IDrelease_xkkfkthq6zf3dcwng5ebdjglvy
P932PMC publication ID4958160
P698PubMed publication ID27297480

P50authorBoualem SendidQ55090913
Eric DannaouiQ56458995
Patrice Le PapeQ61160079
Stéphane RanqueQ85953888
Muriel CornetQ87315118
P2093author name stringA Datry
E Bailly
J Guitard
D Maubon
J P Gangneux
I Accoceberry
C Hennequin
J Chandenier
M-E Bougnoux
A Fekkar
F Botterel
A Dupuis
S Chevrier
F Dalle
M Sautour
Y Le Govic
T Chouaki
A Angoulvant
P2860cites workEchinocandin resistance: an emerging clinical problem?Q28544739
Acquired resistance to echinocandins in Candida albicans: case report and reviewQ34623936
Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden.Q35140020
Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.Q35635472
Candida spp. with acquired echinocandin resistance, France, 2004-2010.Q35845865
Micafungin: pharmacology, experimental therapeutics and clinical applicationsQ36120798
Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006Q36424929
Rapid emergence of echinocandin resistance during Candida kefyr fungemia treatment with caspofungin.Q36785949
Comparison between the EUCAST procedure and the Etest for determination of the susceptibility of Candida species isolates to micafunginQ37263358
Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method.Q37544819
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.Q38058556
Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient managementQ38254290
Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species.Q40345973
Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest mediaQ41939680
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.Q43271946
EUCAST technical note on Candida and micafungin, anidulafungin and fluconazoleQ44013179
Comparison of micafungin MICs as determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27-A3 document) and Etest for Candida spp. isolatesQ44120897
EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeastsQ46812076
Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?Q46908055
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.Q47643534
Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee onQ59286587
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectmulticenter clinical trialQ6934595
P1104number of pages4
P304page(s)5088-5091
P577publication date2016-07-22
P1433published inAntimicrobial Agents and ChemotherapyQ578004
P1476titleMulticenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin
P478volume60

Reverse relations

cites work (P2860)
Q91817088Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait
Q37528498Fluconazole and Echinocandin Resistance of Candida glabrata Correlates Better with Antifungal Drug Exposure Rather than with MSH2 Mutator Genotype in a French Cohort of Patients Harboring Low Rates of Resistance.
Q37287777Intra- and Interlaboratory Agreement in Assessing the In Vitro Activity of Micafungin against Common and Rare Candida Species with the EUCAST, CLSI, and Etest Methods
Q37538775Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method
Q58737037Susceptibility Testing of Fungi to Antifungal Drugs

Search more.